Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 398 followers
Latest posts
Last updated 10 minutes ago
Senate HELP Committee chair pitches proposals for FDA reform
10 minutes ago
In his report, Senator Bill Cassidy suggested a slate of changes to...
J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA
32 minutes ago
With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson...
With an assist from Shaq, Lilly joins Team USA's work to help Olympic athletes rebound from injury
about 1 hour ago
Eli Lilly is partnering on Team USA’s push to help Olympic athletes...
Novartis heads to FDA with Rhapsido after ph. 3 win in untapped chronic hives subtype
about 2 hours ago
Less than half a year after winning an inaugural green light in...
Lilly chalks up another trial win for Zepbound-Taltz combo in bid to break down psoriasis, obesity 'silos'
about 3 hours ago
Six weeks after Eli Lilly revealed the success of phase 3b trial...
EyePoint scopes out new commercial chief to prepare for Duravyu launch
about 5 hours ago
As it looks ahead to the potential launch of its sustained-delivery treatment...
Stada earmarks €85M to build out Middle East production hub in Saudi Arabia
about 20 hours ago
Stada will invest more than 85 million euros (around $101 million) to...
Bayer strikes $7.25B Roundup settlement, favoring 'speed and containment' of thorny legal issue
about 21 hours ago
Bayer has spent years working to get a handle on its Roundup...
‘Hypertension Bites’: AZ-backed coalition launches ’90s-inspired awareness campaign
about 23 hours ago
Shaped primarily by discussions with Gen Xers and older millennials, a new...
Ocular Therapeutix eyes FDA filing with ph. 3 wet AMD win over Eylea, but investors balk
about 24 hours ago
The company is confident that results from a head-to-head trial against Regeneron's...
Lilly's rare cancer drug Retevmo looks to broaden reach with adjuvant trial win
1 day ago
Six years after the FDA approved Eli Lilly’s Retevmo to treat lung...
Roche adds to Gazyva's growing autoimmune pedigree with new phase 3 kidney condition win
1 day ago
Continuing the reinvention of its cancer drug Gazyva as a treatment for...